Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01750242 · ClinicalTrials.gov registry record
Retrospective, Non-significant Risk, Deep Brain Stimulation (DBS) Care Management Software Feasibility Study
A clinical trial of Parkinson's Disease, sponsored by MedtronicNeuro.
- Completed
- Registry status
- 20
- Enrollment target
- 2
- Study locations
NCT01750242: Completed study of Parkinson's Disease, sponsored by MedtronicNeuro.
NCT01750242 is a study of Parkinson's Disease that has completed, run by MedtronicNeuro. The registered enrollment target is 20 participants, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01750242, a study of Parkinson's Disease, has completed, sponsored by MedtronicNeuro.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 2
- Study locations
Study Summary
To evaluate DBS device settings and match with the features of the DBS care management software.
Primary Outcome
The one-sided 95% exact binomial lower confidence bound of the proportion was calculated from subjects with readable images enrolled in the study.
Conditions Studied
Interventions
- DEVICE Medtronic DBS system
Study Locations (2)
California
- Scripps Clinic, Division of Neurology - La Jolla
Kansas
- Parkinson's Disease and Movement Disorder Center, University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-11 |
| Est. Completion | 2013-08 |
What the finished NCT01750242 record still lists
NCT01750242 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 1 intervention - of which Medtronic DBS system is the first listed.
NCT01750242 reports a single indexed study location in California, Kansas.
Frequently Asked Questions
What is clinical trial NCT01750242 about?
NCT01750242 is a clinical study titled "Retrospective, Non-significant Risk, Deep Brain Stimulation (DBS) Care Management Software Feasibility Study". To evaluate DBS device settings and match with the features of the DBS care management software.
What is the current status of trial NCT01750242?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2012-11. Estimated completion is 2013-08.
What conditions does trial NCT01750242 study?
This clinical trial studies the following conditions: Parkinson's Disease.
What interventions are being tested in trial NCT01750242?
The interventions under investigation include: Medtronic DBS system (DEVICE).
Who is sponsoring clinical trial NCT01750242?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01750242 being conducted?
This trial has 2 study locations across California, Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01750242's enrollment target sits among peer trials
20 129th of 158 higher than 24 of 158 other Parkinson's Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease
RECRUITING · NA
-
rTMS to Improve Cognition in Parkinson's
RECRUITING · Phase 1
-
Deep Brain Stimulation for Visuomotor Function in Parkinson's Disease
RECRUITING
-
Ketamine for Veterans With Parkinson's Disease
RECRUITING · Phase 2
-
Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease
RECRUITING · NA
-
PET Imaging Evaluation of [11C]SY08
RECRUITING · Early Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia